National Health Surveillance Agency Anvisa in its website said it received a request from the Brazilian Health Ministry to import 20 million doses of Covaxin.

However a decision on that was suspended by the regulator due to the absence of some key documents.

WHO experts say Chinese jabs show ‘safety’, but data lacking

Apr 1, 2021

The UN health agency’s Strategic Advisory Group of Experts on Immunization (SAGE) said it had reviewed the data provided so far, and that both vaccines “demonstrated safety and good efficacy against symptomatic Covid-19 disease”.

However, it warned, “both vaccines lacked data in older age groups and in persons with co-morbidities,” meaning other medical conditions.

EU drug watchdog reaffirms no particular clot risk factor linked to AstraZeneca vaccine

Apr 1, 2021

While repeating that the vaccine’s benefits outweigh risks, it cautioned that people should be aware of the “remote possibility” of rare blood clots occurring, and must seek immediate medical attention in case of symptoms.

April 1 Renewals:Market pricing remain firm in all classes and territories, Willis Re

Apr 1, 2021

James Kent, Global CEO of Willis Re, said: “The market landscape has not seen much change since 1 January and consequently the important 1 April renewals saw more of the same between reinsurers and their customers. Market results for 2020 illustrate the challenges faced by the global reinsurance sector of reduced investment income, declining prior-year reserve releases, rising COVID-19 loss reserving, and increased volatility in the frequency and severity both of natural catastrophes and man-made losses.

However, reinsurers’ 2020 results, when adjusted for COVID-19 claims reserves, have shown encouraging improvements in underlying combined ratios and buyers’ immediate concerns over capacity availability and pricing have been allayed leading to an orderly renewal.”

« Older Entries

Next Entries »

Briefs